We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.2B
AUM Growth
-$292M
Cap. Flow
-$360M
Cap. Flow %
-29.98%
Top 10 Hldgs %
36.37%
Holding
162
New
39
Increased
27
Reduced
54
Closed
29

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$13.5M
2
MCHP icon
Microchip Technology
MCHP
+$10.8M
3
EQIX icon
Equinix
EQIX
+$10.7M
4
AMT icon
American Tower
AMT
+$10.5M
5
GDDY icon
GoDaddy
GDDY
+$9.38M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$33.1M
2
AAPL icon
Apple
AAPL
+$31.3M
3
DHI icon
D.R. Horton
DHI
+$27M
4
YELP icon
Yelp
YELP
+$26.6M
5
AVGO icon
Broadcom
AVGO
+$21.7M

Sector Composition

Rank Sector Weight
1 Technology 21.97%
2 Financials 21.79%
3 Consumer Discretionary 17.91%
4 Healthcare 16.66%
5 Real Estate 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRM icon
26
Salesforce
CRM
$210B
$15.4M 1.29%
151,100
-65,800
-30% -$6.71M
DHI icon
27
D.R. Horton
DHI
$39.2B
$14.6M 1.22%
285,795
-579,700
-67% -$27M
SNNA
28
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$14.2M 1.18%
785,309
+34,100
+5% +$721K
MU icon
29
Micron Technology
MU
$1.05T
$13.2M 1.1%
320,600
-39,600
-11% -$1.71M
LEN icon
30
Lennar Class A
LEN
$19.3B
$12.9M 1.07%
210,006
-84,148
-29% -$4.78M
GBDC icon
31
Golub Capital BDC
GBDC
$3.23B
$12.4M 1.03%
693,939
– –
LOGM
32
DELISTED
LogMein, Inc.
LOGM
$11.8M 0.98%
103,224
-21,200
-17% -$2.49M
PHM icon
33
Pultegroup
PHM
$22.8B
$11.5M 0.96%
345,294
-513,100
-60% -$15.9M
TSLX icon
34
Sixth Street Specialty
TSLX
$1.7B
$11.1M 0.93%
562,511
+161,948
+40% +$3.32M
CELG
35
DELISTED
Celgene Corp
CELG
$10.8M 0.9%
103,047
+32,200
+45% +$3.63M
MCHP icon
36
Microchip Technology
MCHP
$38.8B
$10.5M 0.88%
+239,800
New +$10.8M
AMT icon
37
American Tower
AMT
$82.8B
$10.5M 0.87%
+73,500
New +$10.5M
EQIX icon
38
Equinix
EQIX
$99.4B
$10.5M 0.87%
+23,110
New +$10.7M
CLVS
39
DELISTED
Clovis Oncology, Inc.
CLVS
$10.5M 0.87%
153,735
+70,000
+84% +$4.89M
CY
40
DELISTED
Cypress Semiconductor
CY
$10.2M 0.85%
671,100
-1,024,200
-60% -$16.3M
ITCI
41
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$10.1M 0.84%
699,950
+41,200
+6% +$636K
LADR
42
Ladder Capital
LADR
$1.21B
$10.1M 0.84%
742,078
-54,700
-7% -$749K
GDDY icon
43
GoDaddy
GDDY
$13B
$9.95M 0.83%
+197,800
New +$9.38M
VRTX icon
44
Vertex Pharmaceuticals
VRTX
$130B
$9.84M 0.82%
65,682
+2,800
+4% +$415K
GWPH
45
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$9.62M 0.8%
72,871
-13,100
-15% -$1.54M
BIDU icon
46
Baidu
BIDU
$30.8B
$9.57M 0.8%
40,872
+948
+2% +$232K
W icon
47
Wayfair
W
$14.2B
$9.42M 0.79%
117,400
+114,000
+3,353% +$8.01M
TCOM icon
48
Trip.com Group
TCOM
$24.7B
$9.13M 0.76%
206,970
-35,400
-15% -$1.69M
ALGN icon
49
Align Technology
ALGN
$10.4B
$9.05M 0.75%
40,745
-59,420
-59% -$13.5M
BIIB icon
50
Biogen
BIIB
$31.9B
$8.83M 0.74%
27,717
-24,955
-47% -$8.01M
1
2
3 4 5

Similar funds

ACG
Allen Capital Group Grand Island, Nebraska $1.23B AUM 19.04% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CCFCSB
Cape Cod Five Cents Savings Bank Orleans, Massachusetts $1.23B AUM
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
OA
Oxbow Advisors Austin, Texas $1.23B AUM 23.59% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.23B AUM 15.23% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return
WVUF
West Virginia University Foundation Morgantown, West Virginia $1.22B AUM 21.82% 1-Year Est. Return

Clough Capital Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Clough Capital Partners held 162 positions worth $1.2B, down 20% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Clough Capital Partners withdrew a net $360M in Q4 2017, closing 29 positions and reducing 54 holdings. Its most notable exit was Yelp, an estimated $26.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Clough Capital Partners opened a new position in Apellis Pharmaceuticals worth $19.7M.

  • Clough Capital Partners's largest Q4 2017 buy was Apellis Pharmaceuticals: 917,116 shares worth $19.7M.
  • Clough Capital Partners added most to Wayfair in Q4 2017, an estimated $8.01M increase.
  • Clough Capital Partners's biggest Q4 2017 reduction was Lam Research, cutting an estimated $33.1M.
  • Clough Capital Partners fully exited Yelp in Q4 2017, selling an estimated $26.6M.
  • Clough Capital Partners's ten largest holdings make up 36% of its $1.2B portfolio in Q4 2017.
  • Clough Capital Partners opened 39 new positions and closed 29 in Q4 2017.
  • Clough Capital Partners's portfolio value fell 20% quarter-over-quarter to $1.2B.

Based on Clough Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.